BARRY MUNSEY: Open Payments
NPI 1508836933 · STAUNTON, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$594 in 32 payments from 7 companies in 2025. Trend: 2023 $1,117 · 2024 $738 · 2025 $594
Food & beverage: $594
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 11 | $166 |
| Otsuka America Pharmaceutical, Inc. | 1 | $119 |
| Lilly USA, LLC | 8 | $108 |
| PFIZER INC. | 4 | $65 |
| AstraZeneca Pharmaceuticals LP | 4 | $65 |
| Novo Nordisk Inc | 3 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $20 |
Products named: OTEZLA, REXULTI, MOUNJARO, PREVNAR 20, FARXIGA, Ozempic, JARDIANCE, REPATHA.
Industry payments across VA — which companies pay providers there.
